ReviewInternational journal of oncology2026

Signaling pathways and targeted therapy in high‑risk refractory thyroid cancer: From bench to bedside (Review).

Jian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.